Effectiveness of RNS60, a Novel Investigational Immunomodulatory and Neuroprotective Agent, for ALS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial
Eur. J. Neurol. 2022 Sep 23;[EPub Ahead of Print], E Beghi, E Pupillo, E Bianchi, V Bonetto, S Luotti, L Pasetto, C Bendotti, M Tortarolo, F Sironi, L Camporeale, AV Sherman, S Paganoni, A Scognamiglio, F De Marchi, P Bongioanni, R Del Carratore, C Caponnetto, L Diamanti, D Martinelli, A Calvo, M Filosto, A Padovani, SC Piccinelli, C Ricci, S Dalla Giacoma, N De Angelis, M Inghilleri, R Spataro, V La Bella, G Logroscino, C Lunetta, C Tarlarini, J Mandrioli, I Martinelli, C Simonini, E Zucchi, MR Monsurrò, D Ricciardi, F Trojsi, N Riva, M Filippi, IL Simone, G Sorarù, C Spera, L Florio, S Messina, M Russo, G Siciliano, A Conte, MV Saddi, N Carboni, L MazziniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.